• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences.

作者信息

Lippert Jörg, Burghaus Rolf, Edginton Andrea, Frechen Sebastian, Karlsson Mats, Kovar Andreas, Lehr Thorsten, Milligan Peter, Nock Valerie, Ramusovic Sergej, Riggs Matthew, Schaller Stephan, Schlender Jan, Schmidt Stephan, Sevestre Michaël, Sjögren Erik, Solodenko Juri, Staab Alexander, Teutonico Donato

机构信息

Clinical Pharmacometrics, Bayer AG, Wuppertal, Germany.

School of Pharmacy, University of Waterloo, Waterloo, Canada.

出版信息

CPT Pharmacometrics Syst Pharmacol. 2019 Dec;8(12):878-882. doi: 10.1002/psp4.12473. Epub 2019 Nov 12.

DOI:10.1002/psp4.12473
PMID:31671256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6930856/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c46/6930856/260c65ec6a6c/PSP4-8-878-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c46/6930856/7e893c2253a8/PSP4-8-878-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c46/6930856/260c65ec6a6c/PSP4-8-878-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c46/6930856/7e893c2253a8/PSP4-8-878-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c46/6930856/260c65ec6a6c/PSP4-8-878-g002.jpg

相似文献

1
Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences.开放系统药理学社区——一种用于药学科学建模与模拟的开放获取、开源、开放科学方法。
CPT Pharmacometrics Syst Pharmacol. 2019 Dec;8(12):878-882. doi: 10.1002/psp4.12473. Epub 2019 Nov 12.
2
Quantitative Systems Pharmacology and Physiologically-Based Pharmacokinetic Modeling With mrgsolve: A Hands-On Tutorial.定量系统药理学和基于生理的药代动力学模型与 mrgsolve：实践教程。
CPT Pharmacometrics Syst Pharmacol. 2019 Dec;8(12):883-893. doi: 10.1002/psp4.12467. Epub 2019 Nov 14.
3
Pharmacometrics and/or Systems Pharmacology.药物计量学和/或系统药理学
CPT Pharmacometrics Syst Pharmacol. 2019 Jun;8(6):331-332. doi: 10.1002/psp4.12376. Epub 2019 Feb 2.
4
A Philosophical Framework for Integrating Systems Pharmacology Models Into Pharmacometrics.将系统药理学模型整合到药物计量学中的哲学框架。
CPT Pharmacometrics Syst Pharmacol. 2016 Dec;5(12):649-655. doi: 10.1002/psp4.12148. Epub 2016 Nov 12.
5
Relevance of systems pharmacology in drug discovery.系统药理学在药物发现中的相关性。
Drug Discov Today. 2012 Jul;17(13-14):665-70. doi: 10.1016/j.drudis.2012.01.015. Epub 2012 Jan 25.
6
American Society for Clinical Pharmacology and Therapeutics 2019 Annual Meeting Pre-Conferences.美国临床药理学与治疗学学会2019年年会会前会议
CPT Pharmacometrics Syst Pharmacol. 2019 Jun;8(6):333-335. doi: 10.1002/psp4.12424. Epub 2019 Jun 4.
7
A Six-Stage Workflow for Robust Application of Systems Pharmacology.一种用于系统药理学稳健应用的六阶段工作流程。
CPT Pharmacometrics Syst Pharmacol. 2016 May;5(5):235-49. doi: 10.1002/psp4.12071. Epub 2016 Apr 16.
8
Integrating systems approaches into pharmaceutical sciences.将系统方法整合到药学领域。
Eur J Pharm Sci. 2008 Sep 2;35(1-2):1-4. doi: 10.1016/j.ejps.2008.05.011. Epub 2008 Jun 14.
9
A Flexible Approach for Context-Dependent Assessment of Quantitative Systems Pharmacology Models.一种用于定量系统药理学模型上下文相关评估的灵活方法。
CPT Pharmacometrics Syst Pharmacol. 2019 Jun;8(6):340-343. doi: 10.1002/psp4.12409. Epub 2019 May 14.
10
Systems pharmacology modeling: an approach to improving drug safety.系统药理学建模：一种提高药物安全性的方法。
Biopharm Drug Dispos. 2014 Jan;35(1):1-14. doi: 10.1002/bdd.1871. Epub 2013 Nov 20.

引用本文的文献

1
Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies.用于CD3双特异性抗体组织靶点结合的全身基于生理的药代动力学建模框架
Pharmaceutics. 2025 Apr 9;17(4):500. doi: 10.3390/pharmaceutics17040500.
2
Translational Pharmacokinetic-Pharmacodynamic Modeling of a Novel Oral Dihydroorotate Dehydrogenase (DHODH) Inhibitor, HOSU-53 (JBZ-001).新型口服二氢乳清酸脱氢酶（DHODH）抑制剂HOSU-53（JBZ-001）的转化药代动力学-药效学模型
Pharmaceutics. 2025 Mar 25;17(4):412. doi: 10.3390/pharmaceutics17040412.
3
Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.

本文引用的文献

1
Establishing a Multidisciplinary Framework to Study Drug-Drug Interactions of Hormonal Contraceptives: An Invitation to Collaborate.建立一个多学科框架来研究激素避孕药的药物相互作用：合作邀请。
CPT Pharmacometrics Syst Pharmacol. 2018 Nov;7(11):706-708. doi: 10.1002/psp4.12357. Epub 2018 Oct 23.
2
Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation.模型引导的药物发现与开发中的良好实践：实践、应用与文档记录
CPT Pharmacometrics Syst Pharmacol. 2016 Mar;5(3):93-122. doi: 10.1002/psp4.12049. Epub 2016 Mar 14.
3
Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK.
利用开源解决方案：首届开放系统药理学（OSP）社区会议的见解
CPT Pharmacometrics Syst Pharmacol. 2025 May;14(5):822-827. doi: 10.1002/psp4.70028. Epub 2025 Apr 3.
4
Application of Machine Learning and Mechanistic Modeling to Predict Intravenous Pharmacokinetic Profiles in Humans.机器学习与机理建模在预测人体静脉药代动力学特征中的应用
J Med Chem. 2025 Apr 10;68(7):7737-7750. doi: 10.1021/acs.jmedchem.5c00340. Epub 2025 Mar 27.
5
Assessing Drug-Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption.使用基于生理学的药代动力学建模（PBPK）方法结合半机制吸收评估BCS 2类化合物BI 730357（维甲酸相关孤儿受体γ拮抗剂，贝武罗根）的药物相互作用和食物效应。
Pharmaceutics. 2025 Mar 1;17(3):314. doi: 10.3390/pharmaceutics17030314.
6
Predicting Pharmacokinetics in Rats Using Machine Learning: A Comparative Study Between Empirical, Compartmental, and PBPK-Based Approaches.使用机器学习预测大鼠体内的药代动力学：经验性、房室模型和基于生理药代动力学模型方法的比较研究
Clin Transl Sci. 2025 Mar;18(3):e70150. doi: 10.1111/cts.70150.
7
Digital twin-enhanced three-organ microphysiological system for studying drug pharmacokinetics in pregnant women.用于研究孕妇药物药代动力学的数字孪生增强型三器官微生理系统。
Front Pharmacol. 2025 Feb 12;16:1528748. doi: 10.3389/fphar.2025.1528748. eCollection 2025.
8
Model-Based Dose Selection of a Sphingosine-1-Phosphate Modulator, Etrasimod, in Patients with Various Degrees of Hepatic Impairment.基于模型的鞘氨醇-1-磷酸调节剂依曲莫德在不同程度肝功能损害患者中的剂量选择
Pharmaceutics. 2024 Dec 1;16(12):1540. doi: 10.3390/pharmaceutics16121540.
9
Evaluation of BCRP-Related DDIs Between Methotrexate and Cyclosporin A Using Physiologically Based Pharmacokinetic Modelling.使用基于生理的药代动力学模型评估甲氨蝶呤和环孢素A之间与乳腺癌耐药蛋白相关的药物相互作用
Drugs R D. 2025 Mar;25(1):1-17. doi: 10.1007/s40268-024-00495-1. Epub 2024 Dec 24.
10
Open science practices among authors published in complementary, alternative, and integrative medicine journals: An international, cross-sectional survey.补充、替代和整合医学期刊作者的开放科学实践：一项国际、横断面调查。
Medicine (Baltimore). 2024 Nov 1;103(44):e40259. doi: 10.1097/MD.0000000000040259.
基于生理的药代动力学（PBPK）模型在支持剂量选择中的应用：美国食品药品监督管理局（FDA）关于PBPK的公开研讨会报告
CPT Pharmacometrics Syst Pharmacol. 2015 Apr;4(4):226-30. doi: 10.1002/psp4.33. Epub 2015 Apr 17.
4
Physiologically Based Models in Regulatory Submissions: Output From the ABPI/MHRA Forum on Physiologically Based Modeling and Simulation.药品监管申报中的基于生理的模型：ABPI/MHRA基于生理的建模与模拟论坛成果
CPT Pharmacometrics Syst Pharmacol. 2015 Apr;4(4):221-5. doi: 10.1002/psp4.30. Epub 2015 Apr 2.
5
A Generic Integrated Physiologically based Whole-body Model of the Glucose-Insulin-Glucagon Regulatory System.通用的基于生理的葡萄糖-胰岛素-胰高血糖素调节系统整体模型
CPT Pharmacometrics Syst Pharmacol. 2013 Aug 14;2(8):e65. doi: 10.1038/psp.2013.40.
6
Regulatory experience with physiologically based pharmacokinetic modeling for pediatric drug trials.用于儿科药物试验的基于生理学的药代动力学建模的监管经验。
Clin Pharmacol Ther. 2012 May;91(5):926-31. doi: 10.1038/clpt.2012.19.